Generation and characterization of two human induced pluripotent stem cell lines from patients with Danon disease
Matthieu Lejars1, Christelle Kabore1, Benjamin Marande1
1Université Paris-Saclay, Université d'Evry, Inserm, IStem, UMR861, Corbeil-Essonnes, France; IStem, CECS, Corbeil-Essonnes, France.
Abstract:
Danon disease (DD) is a rare, X-linked dominant autophagic vacuolar myopathy caused by deficiency of lysosomal-associated membrane protein 2 (LAMP2) and is characterized by cardiomyopathy, skeletal myopathy, and intellectual disability. However, the underlying mechanisms remain unclear. In this study, we report the generation of two induced pluripotent stem cell (iPSC) lines derived from peripheral blood mononuclear cells of patients with DD. These lines were validated for pluripotency markers expression, genomic integrity, vector clearance, and trilineage differentiation potential. Finally, these cell lines provide a good model to study pathological features of the disease and to evaluate potential therapeutic strategies for DD.
Insights
Researchers generated induced pluripotent stem cell (iPSC) lines from Danon disease (DD) patients. These validated iPSC lines offer a valuable model for studying DD mechanisms and testing new therapies.
Area of Science:
- Genetics and Stem Cell Biology
- Rare Genetic Diseases
- Molecular Medicine
Background:
- Danon disease (DD) is a rare X-linked dominant disorder.
- It is caused by LAMP2 deficiency, leading to autophagic vacuolar myopathy.
- Symptoms include cardiomyopathy, skeletal myopathy, and intellectual disability, with unclear underlying mechanisms.
Purpose of the Study:
- To generate and validate induced pluripotent stem cell (iPSC) lines from Danon disease patients.
- To establish a cellular model for investigating DD pathogenesis.
- To facilitate the evaluation of potential therapeutic strategies for DD.
Main Methods:
- Peripheral blood mononuclear cells were collected from DD patients.
- Reprogramming into induced pluripotent stem cells (iPSCs) was performed.
- Validation included pluripotency markers, genomic integrity, vector clearance, and trilineage differentiation.
Main Results:
- Two distinct iPSC lines derived from DD patients were successfully generated.
- These iPSC lines exhibited validated pluripotency and differentiation capabilities.
- Genomic integrity and vector clearance were confirmed.
Conclusions:
- The generated iPSC lines serve as a robust disease model for Danon disease.
- These cellular models are crucial for understanding DD pathology.
- They provide a platform for preclinical testing of novel therapeutic interventions for DD.
More Related Videos
10:48Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions
Published on: November 26, 2014
09:34Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring
Published on: August 6, 2020
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
iPS Cell Differentiation
EPS and iPS Cells in Disease Research
